All manuscripts
Publications CAR T Cells Treg Cells G-Rex®24 Well Plate

Perfusion microbioreactor for CAR-Treg manufacturing

Published Journal iScience

Share
17 pages Perfusion microbioreactor for CAR-Treg manufacturing

Overview

This study ran regulatory T cell expansion and lentiviral transduction inside a closed 1 mL perfusion microbioreactor. Over 12 days it took wild-type Tregs to 10-fold, as far as a G-Rex® 24-well plate did, on 5.1 mL of medium against 20 mL; CAR-Treg yield rose 92% over the plate.

What this paper found

A closed, 1 mL PDMS perfusion microbioreactor (K-MBR) expanded and lentivirally transduced primary human regulatory T cells, producing functional HLA-A2-specific CAR-Tregs. With an optimized daily feeding regime, wild-type Tregs expanded 10-fold over 12 days, matching a G-Rex® 24-well plate while using 5.1 mL of medium rather than 20 mL. In the CAR-Treg workflow, a 72-hour transduction at MOI 5 reached 67% efficiency and CAR-Treg yield rose 92% compared with a 24-well plate, with a 6-fold expansion. K-MBR-made CAR-Tregs suppressed effector T cell proliferation in an antigen-dependent manner as well as plate-made cells. Culture in the device did not alter cell viability or phenotype. All cells came from healthy donors, and in vivo performance was not evaluated.

Note: All experiments used healthy-donor cells and in vitro assays; the authors note that patient-derived cells, scale-out, automation, cGMP compatibility and in vivo behavior remain to be evaluated.

The perfusion microbioreactor supports high transduction efficiency and robust cell expansion, comparable with the G-Rex platform. — William Edwards, Ningjia Sun, Yikai Wang, Yuhan Lu, Cong Wang, Daniela Mastronicola, Cristiano Scottà, Marco Romano, Cesare M. Cejas, Antoine Espinet, Giovanna Lombardi, Ciro Chiappini, iScience

Study details

Authors
William Edwards, Ningjia Sun, Yikai Wang, Yuhan Lu, Cong Wang, Daniela Mastronicola, Cristiano Scottà, Marco Romano, Cesare M. Cejas, Antoine Espinet, Giovanna Lombardi, Ciro Chiappini
Institution
Centre for Craniofacial and Regenerative Biology, King's College London, London, UK · London Centre for Nanotechnology, King's College London, London, UK · Department of Bioengineering, Imperial College London, London, UK · Wenzhou Eye Valley Innovation Centre, Eye Hospital, Wenzhou Medical University, Wenzhou, China · Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK · Department of Biosciences, Centre for Inflammation Research and Translational Medicine, Brunel University, London, UK · MFX (MicrofluidX) Ltd., Stevenage Bioscience Catalyst, Stevenage, UK
Journal
iScience
Year
2026
PMID / PMC
PMID: 41907416 · PMC
G-Rex® model(s)
G-Rex®24 Well Plate
Cell type(s)
CAR T Cells, Treg Cells
Application area
Other
Study phase
Preclinical

How G-Rex® was used

Wild-type Tregs were expanded in a G-Rex® 24-well plate as the benchmark for the K-MBR microbioreactor, using an optimized ScaleReady protocol. A total of 1 x 10^6 Tregs were seeded in 8 mL of X-VIVO 15 medium with 1,000 IU/mL IL-2 and 100 nM rapamycin, and 6 mL of medium was replaced on day 4 and day 8, for 20 mL in total over the 12-day culture (n = 2 devices). Expansion in the K-MBR was in line with the G-Rex®, with no impact on viability, and a density of 5.0 x 10^6 cells/cm² was reported for the G-Rex® platform.

Explore related

Full citation

Edwards W, Sun N, Wang Y, et al. Perfusion microbioreactor for CAR-Treg manufacturing. iScience. 2026;29(4):115246.

Building a similar workflow?

Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.

Start a conversation →